From Ideas To Impact™

We manage commercialisation of inventions, intellectual property and technology transfer to convert research to positive societal impact.

Two persons adjusting something on a robot
take part IES

Want to become a business developer or mentor? Apply here! (external link)

We are constantly looking for talent and enthusiastic people to join commercialising our innovation projects or mentoring the project teams.

submit inv disco

Take part of our survey (external link)

The purpose of the survey is to map the innovation potential in Aalto University in relation to both the researchers' interest to commercialize/productize their research results and the possibilities for utilization of research results. The survey is organized by Aalto University Innovation Services.

IPR guide

IPR guide (external link)

Innovation Services’ Researchers Practical Guide to Intellectual Property offers practical information about intellectual property rights, such as patents and copyrights.


Cooperation Published:

Open position: Business Developer (part-time) field of the microscopy devices

Are you excited about creating an international business from research in the field of microscopy devices to enhance cell-culture repeatability?
Cooperation Published:

Business Developer for future deep-tech startup APPLY NOW

Would you like to grow a deep tech startup? Are you excited about creating an international business from research in the field of micro- and nanotechnology and materials? 
Cooperation Published:

DeepFRST aims for initiating a startup

How can forest owners reconcile timber revenues, carbon sinks, and biodiversity?
Cooperation Published:

Portable and quick analytics tool can revolutionise the pain killer diagnostics market

Fepod Oy Ltd, an Aalto University based start-up, has developed an analysis tool that allows healthcare professionals to measure the concentration of paracetamol, opioids and other painkillers real concentration in a single drop of blood. The company has just received €750 000 in seed funding from Almaral Oy to continue clinical trials and develop sensor technology and a software platform.

Follow us